Stiftung Institut fuer Herzinfarktforschung   Report issue

Academic/Hospital Phase 3 Phase 4
Founded: Ludwigshafen Germany

Organization Overview

First Clinical Trial
2003
NCT00251134
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Stiftung Institut für Herzinfarktforschung | Stiftung Institut fuer Herzinfarktforschung | Stiftung Institut fuer Herzinfarktforschung, Chairman